Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.12
+$0.05 (+0.28%)
Sep 22, 2026, 1:40 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -263.44M | -243.25M | -285.42M | -311.58M | -334.99M | -331.2M | -318.76M | -297.06M | -264.08M | -240.63M | -209.36M | -176.08M | -160.34M | -153.3M | -149.34M | -13.95M | 818K | 15.48M | 24.93M | -91.7M | -91.49M | -85.65M |
Depreciation & Amortization | -148K | -102K | -106K | -109K | 57K | 5K | 8K | 11K | 12K | 12K | 12K | 12K | 17K | 25K | 33K | 40K | 40K | 38K | 43K | 54K | 69K | 82K |
Stock-Based Compensation | 61.46M | 49.18M | 47.5M | 48.55M | 48.4M | 44.51M | 43.03M | 39.06M | 35.44M | 33.61M | 30.95M | 26.87M | 22.91M | 18.78M | 16.02M | 15.71M | 14.73M | 14.03M | 13.32M | 11.42M | 11.11M | 10M |
Other Working Capital | 12.06M | -29.04M | -15.35M | -1.18M | 20.46M | 28.51M | 22.84M | 18.48M | 13.95M | 21.13M | 26.18M | 19.75M | 2.73M | 6.83M | 6.45M | -8.5M | -11.49M | -15.34M | -11.76M | -9.69M | -3.27M | -841K |
Other Non-Cash Items | -19.4M | -3.05M | -5.64M | -7.37M | -11.77M | -12.14M | -12.45M | -12.96M | -13.62M | -13.78M | -14.06M | -12.76M | -9.48M | -5.92M | -2.05M | -822K | -276K | 136K | 442K | 1.41M | 1.23M | 1.04M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -85K |
Change in Working Capital | -49.46M | -80.94M | -79.32M | -40.37M | -4.36M | 12.31M | 13.27M | 12.09M | 1.05M | 15.87M | 31.86M | 19.82M | 20.86M | 9.44M | 1.66M | -11.05M | -21.78M | -19.89M | -9.6M | -8.41M | -1.47M | -3.31M |
Operating Cash Flow | -270.99M | -278.16M | -322.98M | -310.88M | -302.67M | -286.52M | -274.9M | -258.86M | -241.2M | -204.92M | -160.6M | -142.15M | -126.04M | -130.97M | -133.68M | -10.07M | -6.47M | 9.79M | 29.13M | -87.21M | -80.56M | -77.92M |
Capital Expenditures | -227K | -187K | -187K | -131K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -258.2M | -224.66M | -195.81M | -509.01M | -491.92M | -400.21M | -557.05M | -310.03M | -379.4M | -460.41M | -354.61M | -476.2M | -473.31M | -514.67M | -495.35M | -349.69M | -332.8M | -270.26M | -294.72M | -318.08M | -274.36M | -310.73M |
Sales Maturities Of Investments | 472.3M | 459.13M | 486.03M | 448.62M | 445.82M | 373.97M | 337.28M | 342.94M | 365.54M | 458.7M | 472.22M | 472.47M | 422.48M | 339.99M | 308.93M | 241.08M | 257.84M | 266.92M | 253.98M | 273.02M | 221.95M | 158.02M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 225K | 225K | 225K | 96K | -129K | -129K | -129K | n/a | n/a | n/a |
Investing Cash Flow | 213.87M | 234.28M | 290.04M | -60.52M | -46.1M | -26.23M | -219.78M | 32.91M | -13.86M | -1.71M | 117.61M | -3.73M | -50.6M | -174.46M | -186.19M | -108.52M | -75.09M | -3.46M | -40.87M | -45.06M | -52.41M | -152.71M |
Debt Repayment | 250M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | 2K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.53M | n/a | 930K | 348.36M | 351.45M | 352.13M | 353.37M | 6.33M | 5.08M | 5.73M | 6.04M | 6.79M | -8.59M | 11.81M | 9.89M | 37.33M | 52.56M | 31.72M | 32.13M | 7.23M | 5.53M | 5.74M |
Financial Cash Flow | 280.8M | 20.66M | 13.68M | 355.18M | 352M | 352.13M | 353.37M | 264.43M | 263.18M | 263.83M | 264.13M | 169.15M | 153.78M | 174.17M | 172.25M | 118.53M | 133.76M | 118.06M | 118.46M | 147.34M | 147.41M | 250.39M |
Net Cash Flow | 223.69M | -23.22M | -19.27M | -16.21M | 3.24M | 39.38M | -141.31M | 38.47M | 8.12M | 57.2M | 221.14M | 23.28M | -22.86M | -131.26M | -147.61M | -56K | 52.2M | 124.39M | 106.72M | 15.08M | 14.43M | 19.76M |
Free Cash Flow | -271.21M | -278.35M | -323.17M | -311.01M | -302.67M | -286.52M | -274.9M | -258.86M | -241.2M | -204.92M | -160.6M | -142.15M | -126.04M | -130.97M | -133.68M | -10.2M | -6.6M | 9.66M | 29M | -87.21M | -80.56M | -77.92M |
Adj. Free Cash Flow | -332.67M | -327.53M | -370.67M | -359.56M | -351.07M | -331.02M | -317.93M | -297.92M | -276.64M | -238.53M | -191.55M | -169.01M | -148.94M | -149.75M | -149.69M | -25.91M | -21.33M | -4.37M | 15.69M | -98.63M | -91.67M | -87.92M |
Maintenance CapEx | -9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -218K | -187K | -187K | -131K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -270.99M | -278.16M | -322.98M | -310.88M | -302.67M | -286.52M | -274.9M | -258.86M | -241.2M | -204.92M | -160.6M | -142.15M | -126.04M | -130.97M | -133.68M | -10.07M | -6.47M | 9.79M | 29.13M | -87.21M | -80.56M | -77.92M |
Add to Watchlist
Select watchlists to add or remove SNDX